Healthcare Stocks Locking Down Gains Late; EDAP Surges After Receiving EU Marketing Approval

By Staff,

Shutterstock photo

Top Healthcare Stocks

JNJ +0.76%

PFE +0.74%

ABT +1.63%

MRK +0.08%

AMGN +2.78%

Healthcare stocks have turned solidly higher in late trade with the NYSE Healthcare Sector Index rising about 0.4% and shares of healthcare companies in the S&P 500 adding around 0.8% as a group.

In company news, EDAP SA ( EDAP ) is up 7.8% at $2.89 a share after the French medical-device company said it has received the CE Mark from European regulators for its Focal.One robotic tool to treat prostate cancer.

The device combines the latest imaging tools - including MRI localization and contrast-enhanced ultrasound control - with the high-intensity focused ultrasound to target and then destroy tumors with preciously focused heat.

Marketing approvals for the United States are pending.

In other sector news,

(+) CBMX, Said prenatal testing has shown a "significant uptick" during the six months since data from two National Institutes of Health studies showing the value of chromosomal microarray analysis was published.

(-) GNMK, Reduces projected FY13 revenue by $5 mln from its previous guidance, now expecting around $30 mln in yearly revenue. Analysts, on average, have been looking for around $35 mln in revenue this year by the molecular diagnostics company.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing Commodities
Referenced Stocks: EDAP

More from MT Newswires


MT Newswires

MT Newswires

Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by